The goal of the Monotherapy Dose Escalation phase (Part 1) of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tum…

Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more

~Estimated

~$10 – $8,750

NiKang Therapeutics, Inc.NCT06586957

Phase 1

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Antitumor Activity of ARR-002 in Adults With Locally Advanced or Metastatic Ovarian or Endometrial Cancer.

This is a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian o…

Ovarian CancerEndometrial CancerPlatinum-resistant Ovarian Cancer (PROC)+2 more

~Estimated

~$10 – $8,750

ArriVent BioPharma, Inc.NCT07755436